Hormone replacement therapy and risk of new-onset atrial fibrillation after myocardial infarction--a nationwide cohort study.

PLoS One · 2012 · PMC3524193 · PMID 23284717

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In the age group 60 to 79 years, use of systemic estrogen, use of systemic estrogen and progestogen and use of vaginal estrogen were associated with a lower risk of AF, but these estimates did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.